Medical Staff Pulse is
a Publication of the Chief of Staff
Cardiac Treatment Options Debated at Cedars-Sinai Conference

7th Annual Conference Brings Experts Together in an Open Forum

Nationwide, differences of opinion among heart specialists about the effectiveness of various treatments have seemingly reached a fever pitch in the past few years. As a result, there was great interest in a recent major Cedars-Sinai symposium that brought together prominent cardiologists, cardiac surgeons and other medical professionals from Cedars-Sinai and around the country to discuss and debate these differences and controversies in an open forum.

The 7th Annual "Controversies and Advances in the Treatment of Cardiovascular Disease" was held at the Beverly Hills Hotel on October 4 and 5. In addition to Cedars-Sinai, the two-day conference was co-sponsored by the California Chapter of the American College of Cardiology, the California Chapter of the Society of Thoracic Surgeons and Promedica International CME.

Eduardo Marbán, M.D., director of the Cedars-Sinai Heart Institute, was a keynote speaker and discussed stem cell therapy for cardiac regeneration. An expert in molecular and cellular mechanisms underlying heart problems, Dr. Marbán is widely known for directing major multidisciplinary research programs leading to gene therapy, drug treatment and stem cell discoveries.

Other Cedars-Sinai keynote speakers included: Daniel Berman, M.D., Sanjay Kaul, M.D., and Robert J. Siegel, M.D.

Program directors for the conference were Cedars-Sinai's Gregory Fontana, M.D., Raj Makkar, M.D., P.K. Shah, M.D., Alfredo Trento, M.D. and John G. Harold, M.D.